Digest Network Come funziona
Network
/
Società
Co
Non verificato

CorFlow Therapeutics AG

Di cosa scriviamo

BiotecnologiaCardiologiaIndustriaMedicina - VarieSalute

4 comunicati stampa

Guarda tutti i comunicati
30/04/2026
Industria
Salute
Attrezzature medico-sanitarie
Medicina - Varie
Cardiologia
Biotecnologia
CorFlow Therapeutics Announces Successful Completion of Phase 1 and First Patients Enrolled in Phase 2 of the MOCA II Pivotal Trial, Approval to Start the REVITALISE RCT in Europe, and Strengthening of Clinical Leadership
Fonte
CorFlow Therapeutics AG
Emittente
Business Wire
1.00
0
07/07/2025
Scienza
Tecnica
Sanità
Igiene alimentare
Tecnologie Varie
Medicina - Varie
Cardiologia
Salute
Industria
CorFlow Therapeutics Announces FDA Approval of the MOCA-II IDE Pivotal Trial to Validate a Novel Heart Attack Care Technology
Fonte
CorFlow Therapeutics AG
Emittente
Business Wire
1.00
0
06/05/2025
CorFlow Therapeutics Appoints Chris O'Connell as Chairman of the Board of Directors
Fonte
CorFlow Therapeutics AG
Emittente
Business Wire
1.00
0
10/09/2024
Scienza
Attrezzature medico-sanitarie
Medicina - Varie
Cardiologia
Biotecnologia
Salute
Farmaceutica
Industria
CorFlow Therapeutics AG Completes €44 Million Series B Financing to Support the Advancement of a Novel Diagnostic and Drug Delivery Platform for Microvascular Obstruction (MVO) in Heart Attack Patients
Fonte
CorFlow Therapeutics AG
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0